反应 #1797518

ord-a26a6cb982be419891de9650f07f65f0

反应方程式

[BH3-]C#N.[Na+]
Sodium cyanoborohydride
CC(C)(C)c1ccc(N2CCN(c3ccc(C=O)cc3)C2=O)cc1
4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzaldehyde
CC(=O)O
acetic acid
O=C(O)C1CNC1
azetidine-3-carboxylic acid
CC(C)(C)c1ccc(N2CCN(c3ccc(CN4CC(C(=O)O)C4)cc3)C2=O)cc1
title product
收率 10.0%
CC(C)(C)c1ccc(N2CCN(c3ccc(CN4CC(C(=O)O)C4)cc3)C2=O)cc1
1-(4-(3-(4-tert-Butylphenyl)-2-oxoimidazolidin-1-yl)benzyl)azetidine-3-carboxylic acid
收率 10.0%

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    workup.STIRRINGthe reaction mixture was stirred for 6 hour at room temperature
  2. 2
    过滤filtered
  3. 3
    其他purified by reverse phase preparative HPLC (Phenomenex

实验过程

A mixture of 4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzaldehyde (32 mg, 0.1 mmol), acetic acid (50 μl) and azetidine-3-carboxylic acid (13 mg, 0.13 mmol) in dichloromethane/MeOH (1:1, 5 mL) was stirred at room temperature for 1 hour. Sodium cyanoborohydride (3.5 mg, 0.05 mmol) was added and the reaction mixture was stirred for 6 hour at room temperature. After concentration of solvent under reduced pressure, the resulting residue was dissolved in dimethylsulfoxide, filtered and purified by reverse phase preparative HPLC (Phenomenex reverse phase Luna 5u C18(2) column, 60×21.2 mm ID, mobile phase: A=0.05% TFA in water; B=0.05% TFA in acetonitrile. The flow rate was 10-12 mL/min) to yield the title product 4 mg (10%): 1H NMR (400 MHz, CDOD3) δ 7.72 (d, 2H), 7.51-7.40 (m, 6H), 4.33 (s, 2H), 4.28 (m, 4H), 4.02 (s, 4H), 3.64 (m, 1H), 1.32 (s, 9H). MS (ESI) m/z: Calculated: 407.22; Observed: 408.00 (M++1).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US07790707B2uspto-grants-2010_09